IROBOT CORP (IRBT)
US4627261005 - Common Stock
Taking everything into account, IRBT scores 1 out of 10 in our fundamental rating. IRBT was compared to 66 industry peers in the Household Durables industry. Both the profitability and financial health of IRBT have multiple concerns. IRBT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year IRBT has reported negative net income.
In the past year IRBT has reported a negative cash flow from operations.
In multiple years IRBT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: IRBT reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of IRBT (-34.34%) is worse than 90.77% of its industry peers.
With a Return On Equity value of -105.35%, IRBT is not doing good in the industry: 89.23% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.34% | ||
| ROE | -105.35% | ||
| ROIC | N/A |
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of IRBT (22.23%) is worse than 73.85% of its industry peers.
In the last couple of years the Gross Margin of IRBT has declined.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%
2. Health
2.1 Basic Checks
IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IRBT has been increased compared to 1 year ago.
The number of shares outstanding for IRBT has been increased compared to 5 years ago.
Compared to 1 year ago, IRBT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.20, we must say that IRBT is in the distress zone and has some risk of bankruptcy.
IRBT has a Altman-Z score of 1.20. This is amonst the worse of the industry: IRBT underperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.83 indicates that IRBT is somewhat dependend on debt financing.
IRBT's Debt to Equity ratio of 0.83 is on the low side compared to the rest of the industry. IRBT is outperformed by 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.2 |
ROIC/WACCN/A
WACC10.13%
2.3 Liquidity
IRBT has a Current Ratio of 1.79. This is a normal value and indicates that IRBT is financially healthy and should not expect problems in meeting its short term obligations.
IRBT has a Current ratio of 1.79. This is in the lower half of the industry: IRBT underperforms 70.77% of its industry peers.
A Quick Ratio of 1.15 indicates that IRBT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.15, IRBT is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
IRBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.67%.
Looking at the last year, IRBT shows a very negative growth in Revenue. The Revenue has decreased by -16.30% in the last year.
IRBT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.01% yearly.
EPS 1Y (TTM)-42.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.38%
Revenue 1Y (TTM)-16.3%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Sales Q2Q%-6.41%
3.2 Future
The Earnings Per Share is expected to grow by 22.64% on average over the next years. This is a very strong growth
IRBT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.06% yearly.
EPS Next Y60.37%
EPS Next 2Y34.38%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue Next Year-6.1%
Revenue Next 2Y-2.43%
Revenue Next 3Y-0.06%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for IRBT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRBT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IRBT's earnings are expected to grow with 22.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.38%
EPS Next 3Y22.64%
5. Dividend
5.1 Amount
IRBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IROBOT CORP
NASDAQ:IRBT (7/26/2024, 7:00:02 PM)
After market: 12.6899 +0.05 (+0.39%)12.64
-0.21 (-1.63%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap363.53M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.34% | ||
| ROE | -105.35% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.23% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-42.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y60.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.3%
Revenue growth 3Y-14.61%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y